Immune Checkpoints in Cancers: From Signaling to the Clinic

SIMPLE SUMMARY: Immune checkpoint therapies are treatments used to fight cancers by reactivating a patient’s own immune system. Melanoma was the first cancer to benefit from these treatments. Despite a clear benefit for patients and the existence of long responders, most patients fail to respond or...

Descripción completa

Detalles Bibliográficos
Autores principales: Pisibon, Céline, Ouertani, Amira, Bertolotto, Corine, Ballotti, Robert, Cheli, Yann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468441/
https://www.ncbi.nlm.nih.gov/pubmed/34572799
http://dx.doi.org/10.3390/cancers13184573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468441/
https://www.ncbi.nlm.nih.gov/pubmed/34572799
http://dx.doi.org/10.3390/cancers13184573

Ejemplares similares